Actithera
Manufacturing · Norway · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Kjelsåsveien 168b, Oslo, Oslo, 0884, Nor...Phone Number
(617) 780-8045Website
www.actithera.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Actithera
Actithera is a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs). Founded in 2021 by drug discovery innovator Dr. Andreas Goutopoulos, and seed investors M Ventures, and Arkin Bio Ventures II, Actithera applies various molecular design strategies, including covalent-targeting and an isotope-agnostic philosophy to invent RLTs with significant differentiation and larger therapeutic windows. Headquartered in Oslo, Norway, and Cambridge, Massachusetts, Actithera is committed to advancing a differentiated pipeline addressing critical unmet needs in oncology.Explore more
Actithera Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Actithera your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Actithera has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Actithera had a recent Job posting/layoffs
Actithera, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Actithera is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Actithera has new funding data
Earning: See what the market has to say on Actithera recently announced quarterly report
Product Launch: Get notified when Actithera launches new products
Congratulate Masked Content for being promoted to Masked Content at Actithera
Recommended Actions
Find VP level buyers at Actithera
Find more new buyers
Company Profile Activity
Activity Insights
Actithera is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Actithera is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Actithera.
Actithera financials insights
Gather financial insights about Actithera, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$75.5M
Actithera Tech Stack
A closer look at the technologies used by Actithera
Most Recent Scoops
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Hiring Plans
Actithera has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Open Position
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Actithera News & Media
Actithera appoints radiopharmaceutical pioneer Dr. Darshan Dalal as Chief Medical Officer
OSLO, Norway and CAMBRIDGE, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Actithera (“the Company”), a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs), today announced the appointment of Darshan Dalal, M.D., PhD, MPH as Chief Medical Officer (CMO). In this role, Dr. Dalal will lead the clinical strategy and build the clinical development organization as Actithera advances its lead fibroblast activation protein (FAP)-targetActithera Secures Exclusive Rights to Innovative Covalent Chemistry Technologies from Weizmann Institute for Targeted Radiopharmaceutical Applications
Exclusive license via Yeda to two Weizmann Institute patent families from Prof. Nir London's lab, a leader in covalent drug design Site-specific, durable and traceless protein radiolabeling approaches intended to enhance tumor selectivity and retention in radiopharmaceuticals Integration...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Actithera
Sign Up For FreeTo access detailed company insights
Actithera is a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs). Founded in 2021 by drug discovery innovator Dr. Andreas Goutopoulos, and seed investors M Ventures, and Arkin Bio Ventures II, Actithera applies various molecular design strategies, including covalent-target... Read More
